ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the molecular setting, the increased telomere shortening in the peripheral blood myeloid cells in CML patients was substantiated by the accelerated cellular turnover of clonal BCR-ABL-positive hematopoietic stem progenitor cells (HSPCs) [156].